- Home
- JBDI vs IRIX Comparison
JBDI vs IRIX Comparison
Compare JBDI & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBDI
- IRIX
- Stock Information
- Founded
- JBDI 1983
- IRIX 1989
- Country
- JBDI Singapore
- IRIX United States
- Employees
- JBDI N/A
- IRIX N/A
- Industry
- JBDI
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JBDI
- IRIX Health Care
- Exchange
- JBDI Nasdaq
- IRIX Nasdaq
- Market Cap
- JBDI 19.0M
- IRIX 16.5M
- IPO Year
- JBDI 2024
- IRIX 1996
- Fundamental
- Price
- JBDI $0.95
- IRIX $1.41
- Analyst Decision
- JBDI
- IRIX
- Analyst Count
- JBDI 0
- IRIX 0
- Target Price
- JBDI N/A
- IRIX N/A
- AVG Volume (30 Days)
- JBDI 36.8K
- IRIX 140.2K
- Earning Date
- JBDI 02-15-2025
- IRIX 08-07-2025
- Dividend Yield
- JBDI N/A
- IRIX N/A
- EPS Growth
- JBDI N/A
- IRIX N/A
- EPS
- JBDI N/A
- IRIX N/A
- Revenue
- JBDI $9,017,000.00
- IRIX $48,804,000.00
- Revenue This Year
- JBDI N/A
- IRIX $9.61
- Revenue Next Year
- JBDI N/A
- IRIX N/A
- P/E Ratio
- JBDI N/A
- IRIX N/A
- Revenue Growth
- JBDI N/A
- IRIX N/A
- 52 Week Low
- JBDI $0.49
- IRIX $0.78
- 52 Week High
- JBDI $39.41
- IRIX $2.14
- Technical
- Relative Strength Index (RSI)
- JBDI N/A
- IRIX 73.03
- Support Level
- JBDI N/A
- IRIX $1.31
- Resistance Level
- JBDI N/A
- IRIX $1.45
- Average True Range (ATR)
- JBDI 0.00
- IRIX 0.12
- MACD
- JBDI 0.00
- IRIX 0.04
- Stochastic Oscillator
- JBDI 0.00
- IRIX 71.87
About JBDI JBDI Holdings Limited Ordinary Shares
JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.